The names on this page are hidden. Create a free account to reveal 5 records a month, or get Private Equity Intelligence at $249 a month for every name. Every figure, date and source on this page is public either way.

Transactions / T••••••••• I•••

T••••••• S••••• Capital Partners Portfolio Company Isto B•••••••• Acquires T••••••••

Add-on acquisitionclosedadd-onannounced Apr 5, 2022closed Apr 5, 2022Fact
What happened
Target
T••••••••• I•••
Platform
I••• B•••••••• •add-on basis: T••••••• S••••• Capital Partners (TSCP), a private equity firm based in St. Louis, today announced its portfolio company Isto B••••••••, a leader in surgical-based, osteo-biologic regeneration technologies and cell-based therapies, has acquired T••••••••• I•••, a California-based regenerative medicine company.
Control
Control
Share acquired
unknown
Industry
unknown
Target location
unknown
Seller kind
unknown
Rollover
unknown
Values, only where disclosed
Enterprise value
Not disclosed
Purchase price
Not disclosed
Equity value
Not disclosed
Target revenue
Not disclosed
Target EBITDA
Not disclosed
Multiple
Not disclosed
Parties and roles
6 named
Buy side
Side not stated
Evidence
“••• Locked”
Press release wires (PR Newswire, GlobeNewswire, Business Wire public pages and RSS)confidence 80%recorded Sep 15, 2026